Efficacy and safety of canagliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin and sulphonylurea: a randomised trial.

Int J Clin Pract · 2013 · PMC4282288 · PMID 24118688

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Canagliflozin 100 and 300 mg showed numerical increases in HDL-C and decreases in triglycerides relative to placebo at week 26, but these differences did not reach statistical significance (Table 4 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.